ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Atorvastatin suppresses lipopolysaccharide-induced inflammation in human coronary artery endothelial cells

Tian, Zhen; Li, Zhitao; Guo, Tian; Li, He; Mu, Yanshuang*东北农业大学; 哈尔滨医科大学
Brazilian Journal of Pharmaceutical Sciences2022DOI: 10.1590/s2175-979020200001181092
7阅读
引用收藏
分享

摘要

The present study was designed to examine the effects of atorvastatin on vascular inflammatory responses in human coronary artery endothelial cells(HCAECs), when challenged by lipopolysaccharide (LPS), a Toll-like receptor-4 (TLR4) ligand. HCAECs were pretreated with atorvastatin and induced by LPS. The expression of TLR4, interleukin -6(IL-6), monocyte chemoattractant protein 1(MCP-1), vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecular-1(ICAM-1), nuclear factor-kappa B (NF-kappa B) and p38 mitogen activated protein kinase(p38 MAPK) were evaluated using Real-time polymerase chain reaction, cytokine ELISA assay and Western blotting. The results showed that pretreatment with atorvastatin down-regulated the expression of TLR4 in LPS-activated HCAECs. Atorvastatin also attenuated the LPS-induced expression of interleukin IL-6 and MCP-1, at both the transcription and translation level in HCAECs. LPS-induced endothelial cell adhesion molecules, ICAM-1 and VCAM-1 expression were also reduced by pretreatment with atorvastatin. Furthermore, atorvastatin efficiently suppressed LPS-induced phosphorylation of NF-kappa B and p38 MAPK in HCAECs. These findings show that atorvastatin suppresses endothelial cell inflammation, suggesting that atorvastatin may be suitable for development as a therapeutic agent for inflammatory cardiovascular disease.

学科与关键词

关键词
AtorvastatinTLR4LipopolysaccharideEndothelial cellsInflammation
相关
加载中…
  • Inhibition of EphA2 protects against atherosclerosis by synergizing with statins to mitigate macrophage inflammation
    Zeng, Jie; Wu, Qiao; Xiong, Shiqiang; Lu, Cong; Zhang, Zheng; Huang, Hui; Xiong, Yan; Luo, Tiantian*Biomedicine and Pharmacotherapy, 2023, 169: 115885.
  • 阿托伐他汀通过下调PAPP-A、MMP3 mRNA表达抑制rhCRP诱导的人动脉平滑肌细胞炎症反应
    廖丽贞; 唐凯; 梅卫义; 陆立鹤广州医学院学报, 2013, (06): 10-14.
  • Effects of Rosuvastatin on Fibrinolytic System of Human Umbilical Vein Endothelial Cells In Vitro
    He Fei*; Zhao Jing; Guo Rong; Liang YingAMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2014, 348(4): 319-323.
查看全部 →

发表信息

论文状态
公开发表
期刊
Brazilian Journal of Pharmaceutical Sciences
发表日期
2022
卷期
第 58 卷
页码
e181092
DOI
10.1590/s2175-979020200001181092
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
Open Projects of Key Laboratory of Animal Cellular and Genetic Engineering of Heilongjiang Province [KF201707]

作者

  • T

    Tian, Zhen (第一作者)

    harbin med univ · northeast agr univ

  • L

    Li, Zhitao

    harbin med univ

查看全部 5 位作者收起作者
  • G

    Guo, Tian

    harbin med univ

  • L

    Li, He

    harbin med univ

  • M

    Mu, Yanshuang (通讯)

    northeast agr univ · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417